Valcyte is an antiviral drug mainly used to treat cytomegalovirus infection and related diseases, with the effects of inhibiting virus replication and preventing infection.

1. Main indications

(1) Cytomegalovirus retinitis: used to treat cytomegalovirus retinitis in patients with AIDS.

(2) Post transplant prevention: Used to prevent cytomegalovirus infection in patients undergoing kidney, heart, pancreas kidney combined transplantation.

2 Pharmacological effects

(1) Antiviral mechanism: Wansaiwei is converted into ganciclovir in the body, which inhibits viral DNA polymerase and blocks the synthesis of cytomegalovirus DNA.

(2) Selective effect: Highly selective towards cytomegalovirus, with low toxicity to host cells.

3 Clinical efficacy

(1) Therapeutic effect: It can effectively control the progression of cytomegalovirus retinitis and improve the patient's vision.

(2) Preventive effect: significantly reduces the incidence of cytomegalovirus infection in organ transplant patients.